Nantahala Capital Management Lowers stake in Dolby Laboratories (DLB)

Dolby Laboratories (DLB) : Nantahala Capital Management reduced its stake in Dolby Laboratories by 6.64% during the most recent quarter end. The investment management company now holds a total of 839,807 shares of Dolby Laboratories which is valued at $41,738,408 after selling 59,736 shares in Dolby Laboratories , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Dolby Laboratories makes up approximately 6.53% of Nantahala Capital Management’s portfolio.

Other Hedge Funds, Including , Capital World Investors boosted its stake in DLB in the latest quarter, The investment management firm added 640,437 additional shares and now holds a total of 5,485,058 shares of Dolby Laboratories which is valued at $272,607,383. Dolby Laboratories makes up approx 0.07% of Capital World Investors’s portfolio. Alta Park Capital Lp added DLB to its portfolio by purchasing 70,000 company shares during the most recent quarter which is valued at $3,479,000. Dolby Laboratories makes up approx 4.86% of Alta Park Capital Lp’s portfolio. Wbi Investments added DLB to its portfolio by purchasing 47,186 company shares during the most recent quarter which is valued at $2,345,144. Dolby Laboratories makes up approx 0.08% of Wbi Investments’s portfolio.Los Angeles Capital Management Equity Research Inc reduced its stake in DLB by selling 300 shares or 2.34% in the most recent quarter. The Hedge Fund company now holds 12,530 shares of DLB which is valued at $622,490. Dolby Laboratories makes up approx 0.01% of Los Angeles Capital Management Equity Research Inc’s portfolio.California Public Employees Retirement System reduced its stake in DLB by selling 900 shares or 0.41% in the most recent quarter. The Hedge Fund company now holds 219,700 shares of DLB which is valued at $10,710,375. Dolby Laboratories makes up approx 0.02% of California Public Employees Retirement System’s portfolio.

Dolby Laboratories opened for trading at $48.93 and hit $49.15 on the upside on Thursday, eventually ending the session at $48.96, with a gain of 0.04% or 0.02 points. The heightened volatility saw the trading volume jump to 2,47,877 shares. Company has a market cap of $4,943 M.

On the company’s financial health, Dolby Laboratories reported $0.76 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.66. The company had revenue of $277.60 million for the quarter, compared to analysts expectations of $268.04 million. The company’s revenue was up 19.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.49 EPS.

Many Wall Street Analysts have commented on Dolby Laboratories. Company shares were Reiterated by Dougherty & Company on Jul 28, 2016 to “Buy”, Firm has raised the Price Target to $ 57 from a previous price target of $54 .

Dolby Laboratories Inc. (Dolby Laboratories) creates audio imaging and communication technologies that transform entertainment and communications at the cinema at home at work and on mobile devices. The Company licenses its audio technologies and also develops technologies aimed at enhancing voice conferencing communications and imaging. Additionally the Company provides products and services that enable entertainment content creators and distributors to produce encode transmit and playback content for consumer experiences. The Company designs and manufactures audio and imaging products for the film production cinema and television broadcast industries. Distributed in approximately 80 countries these products are used in content creation distribution and playback to enhance image and sound quality and improve transmission and playback.

Leave a Reply

Dolby Laboratories - Is it time to Sell?

Top Brokerage Firms are advising their investors on Dolby Laboratories. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.